Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amantadine for depressive symptoms and cognitive deficits in BDV-infected affective psychosis
DRKS00007649Phase 2Completed
- Sponsor
- Medizinische Hochschule Hannover
- Start
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of amantadine in bipolar disorder (BD), major depressive episode (MDE), recurrent depressive disorder (RDD), sponsored by Medizinische Hochschule Hannover. Started Mar 2015; status: completed.
02
Drugs
amantadine
03
Conditions
bipolar disorder (BD)major depressive episode (MDE)recurrent depressive disorder (RDD)
Beyond the preview
Go deeper on DRKS00007649.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00007649.